跳转至内容
Merck
CN

SML0040

Sigma-Aldrich

洛美曲索水合物

≥95% (HPLC), powder, GARFTase inhibitor

别名:

LY 264618水合物, N-[4-[2-[(6R)-2-氨基-3,4,5,6,7,8-四氢-4-氧吡啶并[2,3-d]嘧啶-6-基]乙基]苯甲酰基]-L-谷氨酸水合物

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H25N5O6 · xH2O
分子量:
443.45 (anhydrous basis)
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

产品名称

洛美曲索水合物, ≥95% (HPLC)

质量水平

方案

≥95% (HPLC)

表单

powder

颜色

white to light yellow

溶解性

DMSO: ≥5 mg/mL

储存温度

2-8°C

SMILES字符串

O.NC1=NC(=O)C2=C(NC[C@H](CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C2)N1

InChI

1S/C21H25N5O6.H2O/c22-21-25-17-14(19(30)26-21)9-12(10-23-17)2-1-11-3-5-13(6-4-11)18(29)24-15(20(31)32)7-8-16(27)28;/h3-6,12,15H,1-2,7-10H2,(H,24,29)(H,27,28)(H,31,32)(H4,22,23,25,26,30);1H2/t12-,15+;/m1./s1

InChI key

AEFQSKJUVDZANQ-YLCXCWDSSA-N

应用

使用洛美曲索水合物比较人GARFTase有效抑制剂的生物学活性。

生化/生理作用

甘氨酰胺核糖核苷酸甲酰基转移酶(GARFTase)是从头嘌呤合成所需的叶酸依赖性酶。 洛美曲索是GARFTase的有效抑制剂,但不会干扰叶酸合成中涉及的酶。 已在临床上测试了洛美曲索作为一种类似于甲氨蝶呤的抗叶酸药物,用于治疗各种癌症。 用洛美曲索治疗可迅速降低ATP和GTP水平,使细胞周期停滞并诱导细胞凋亡。 尽管核苷酸库的消耗会诱导p53表达,但洛美曲索在野生型和突变型表达p53的肿瘤细胞中均具有细胞毒性。 洛美曲索对CCRF-CEm白血病细胞具有细胞毒性,IC50为2.9 nM。

象形图

Skull and crossbones

警示用语:

Danger

危险声明

危险分类

Acute Tox. 3 Oral

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

New agents in cancer clinical trials.
J Adams et al.
Oncogene, 19(56), 6687-6692 (2001-06-28)
Robert Mauritz et al.
Biochemical pharmacology, 63(2), 105-115 (2002-02-14)
We determined the mechanisms of resistance of human CCRF-CEM leukemia cells to methotrexate (MTX) vs. those to six novel antifolates: the polyglutamatable thymidylate synthase (TS) inhibitors ZD1694, multitargeted antifolate, pemetrexed, ALIMTA (MTA) and GW1843U89, the non-polyglutamatable inhibitors of TS, ZD9331
Julie L Bronder et al.
Cancer research, 62(18), 5236-5241 (2002-09-18)
The class of folate antimetabolites typified by (6R)-dideazatetrahydrofolate (lometrexol, DDATHF) are specific inhibitors of de novo purine synthesis because of potent inhibition of glycinamide ribonucleotide formyltransferase (GART) but do not induce detectable levels of DNA strand breaks. As such, they
D R Newell
Seminars in oncology, 26(2 Suppl 6), 74-81 (1999-12-22)
Antifolate drugs, as a class, have broad-spectrum activity against both hematologic and solid human malignancies. The pharmacokinetics of the classical antifolate methotrexate have been well-defined and pharmacokinetic data can be exploited to reduce the toxicity and enhance the activity of
R Zhao et al.
The Journal of biological chemistry, 275(34), 26599-26606 (2000-06-17)
Four L1210 murine leukemia cell lines resistant to 5, 10-dideazatetrahydrofolate (DDATHF) and other folate analogs, but sensitive to continuous exposure to methotrexate, were developed by chemical mutagenesis followed by DDATHF selective pressure. Endogenous folate pools were modestly reduced but polyglutamate

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门